AmeriPath

AmeriPath is the leading national provider of anatomic pathology, dermatopathology, and molecular diagnostic services in the United States. It operates as part of Quest Diagnostics since its acquisition in 2007. The company offers comprehensive diagnostic solutions with over 450 board-certified pathologists specializing in multiple subspecialties. Services include surgical pathology, cytopathology, immunohistochemistry, flow cytometry, cytogenetics, next-generation sequencing-based molecular diagnostics, and companion diagnostics for oncology treatment selection. AmeriPath supports hospitals, clinics, surgery centers, physicians’ offices and other healthcare providers nationwide with rapid turnaround times and advanced technology.